½ÃÀ庸°í¼­
»óǰÄÚµå
1608145

¼¼°èÀÇ À§³» dz¼± ½ÃÀå : Åõ¿© ¹æ¹ýº°, dz¼± À¯Çüº°, ÃæÀü Àç·áº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Intragastric Balloon Market by Administration (Endoscopy, Pill Form), Balloon Type (Dual, Single, Triple), Filling Material, End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À§³» dz¼± ½ÃÀåÀº 2023³â¿¡ 2,016¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 2,195¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 8.25%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 3,512¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À§³» dz¼± ½ÃÀåÀÇ ¹üÀ§´Â ºñ¸¸°ú °ü·ÃµÈ ÇÕº´ÁõÀ¸·Î °íÅë¹Þ´Â »ç¶÷µéÀÇ Ã¼Áß °¨¼Ò¸¦ µ½±â À§ÇØ À§ ³»ºÎ¿¡ ¹èÄ¡µÈ Àúħ½ÀÀ¸·Î ÀϽÃÀûÀΠüÁß °¨·® ÀåÄ¡·Î »ç¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. dz¼±ÀÌ ÇÊ¿äÇÑ ¹è°æ¿¡´Â ºñ¸¸ À¯º´·ü Áõ°¡, üÁß °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, ºñ ¼ö¼ú °³ÀÔÀÇ ±âÈ£°¡ ÀÖ½À´Ï´Ù. À§³» dz¼±Àº ÁÖ·Î ÀÓ»ó ÇöÀåÀ̳ª üÁß °¨·® ½Ã¼³¿¡¼­ »ç¿ëµÇ¸ç »ýȰ ½À°üÀÇ °³¼±À̳ª ¿µ¾ç Áöµµ, °æ¿ì¿¡ µû¶ó¼­´Â ¾à¼öó¸®ÀÇ º¸Á¶ÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ȯÀÚ»Ó¸¸ ¾Æ´Ï¶ó Á¾ÇÕÀûÀΠüÁß °ü¸® ÇÁ·Î±×·¥À» Á¦°øÇÏ´Â ÀÇ·á Á¦°ø¾÷ü ¹× À£´Ï½º ¼¾ÅÍ¿¡µµ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 2,016¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 2,195¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 3,512¸¸ ´Þ·¯
CAGR(%) 8.25%

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ºñ¸¸·üÀÇ »ó½Â, °Ç°­ ÀǽÄÀÇ Çâ»ó, ÀÇ·á ±â¼úÀÇ Áøº¸¿¡ ÀÇÇÑ À§³» dz¼±ÀÇ À¯È¿¼º°ú ¾ÈÀü¼ºÀÇ Çâ»óÀÔ´Ï´Ù. °Ô´Ù°¡ ÃÖ±Ù ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ̳ª µðÁöÅÐ ¸ð´ÏÅ͸µ ÅøÀÇ µµÀÔÀº ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í, ±â¾÷Àº ȯÀÚÀÇ ¾ÖµåÈ÷¾î·±½º³ª Àü±ÍÀÇ ÃßÀû¿¡ À־ Çõ½ÅÀûÀÎ ´ëó¸¦ ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ȯÀÚ ÀΰÔÀÌÁö¸ÕÆ®¸¦ À§ÇÑ ÅëÇÕ ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀ̳ª °æ°ú¸¦ ÃßÀûÇϱâ À§ÇÑ µ¥ÀÌÅÍ ºÐ¼®À» ¸ð»öÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇØ ȯÀÚ¿Í ÀÇ·á Á¦°øÀÚ ¸ðµÎ¿¡°Ô ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå È®´ë¿¡´Â ¼ö±â ºñ¿ë, ºÎÀÛ¿ë °¡´É¼º, Á¤±âÀûÀÎ ÈÄ¼Ó Á¶Ä¡ÀÇ Çʿ伺 µîÀÇ Á¦¾àÀÌ ÀÖÀ¸¸ç, À̰ÍÀÌ È¯ÀÚÀÇ Ã¤¿ëÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ³·Àº ÀÎÁöµµ ¹× º¸Çè »óȯÀÇ Á¦Çѵµ Å« °úÁ¦À̸ç, º¸±ÞÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

ÀÌ ºÎ¹®¿¡¼­´Â Æí¾ÈÇÔ°ú ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇÑ »ýºÐÇØ¼º dz¼± °³¹ß, dz¼± Àç·á °³¼±, ½Ã³ÊÁö È¿°ú¸¦ ¸ñÇ¥·Î ÇÏ´Â »õ·Î¿î üÁß °¨·® Ä¡·á¿ÍÀÇ Á¶ÇÕ ¿¬±¸ µîÀÌ Çõ½ÅÀÇ ÃÊÁ¡ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº °æÀïÀÌ ¸¹±â ¶§¹®¿¡ °¡°Ý Àü·«°ú ÀÇ·á ÇÁ·Î¹Ù ¿¡´õ¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁÖ·ÂÇÏ¿© ÁøÀÔ ¹× ÀÌ¿ëÀ» È®´ëÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ÀüüÀûÀ¸·Î Áö¼ÓÀûÀÎ Á¶»ç, ±â¼ú ÅëÇÕ, Æ÷°ýÀûÀÎ ½ÃÀå ±³À° Àü·«À» ÅëÇØ ±× ÇѰ迡 ´ëóÇϰíÀÚ ÇÏ´Â ÀÇ¿åÀÌ ÀÖ´Â »ç¶÷µé¿¡°Ô, À§³» dz¼± ½ÃÀåÀº À¯¸ÁÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â À§³» dz¼± ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À§³» dz¼± ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °Ç°­¿¡ ÇØ·Î¿î ¶óÀÌÇÁ ½ºÅ¸ÀÏÀ̳ª ½Ä½À°ü¿¡ ÀÇÇÑ ºñ¸¸ Àα¸ Áõ°¡
    • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ È¯ÀÚÀÇ °æÇâ
    • ºñ¸¸Ä¡·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ Àǽİú ÁöÃâ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ä¡·á¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • °¢±¹¿¡¼­ Çコ Åõ¾î¸®Áò µ¿ÇâÀÇ °íÁ¶
    • Á¦Ç°ÀÇ º¸±ÞÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ¿Í ¹Î°£ÀÇ Á¦ÈÞ
  • ½ÃÀåÀÇ °úÁ¦
    • À§¹è¶õ µîÀÇ ºÎÀÛ¿ëÀÇ °¡´É¼º

Porter's Five Forces : À§³» dz¼± ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À§³» dz¼± ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À§³» dz¼± ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ¼³¸íÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : À§³» dz¼± ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

À§³» dz¼± ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : À§³» dz¼± ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À§³» dz¼± ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : À§³» dz¼± ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

À§³» dz¼± ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®´ë °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡µµ ´äº¯Çϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °Ç°­¿¡ ÇØ·Î¿î ¶óÀÌÇÁ ½ºÅ¸Àϰú ½Ä½À°ü¿¡ ÀÇÇÑ ºñ¸¸ Àα¸ Áõ°¡
      • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ È¯ÀÚÀÇ °æÇâ
      • ºñ¸¸Ä¡·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ Àǽİú ÁöÃâ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·á¿¡ µå´Â °í¾×ÀÇ ºñ¿ë
    • ±âȸ
      • ¿©·¯ ±¹°¡¿¡¼­ °Ç°­ °ü±¤ µ¿Çâ Áõ°¡
      • Á¦Ç°ÀÇ º¸±Þ·ü Çâ»óÀ» ÇâÇÑ Á¤ºÎ¿Í ¹Î°£ÀÇ Á¦ÈÞ
    • °úÁ¦
      • À§ÀÇ ºñ¶õ µî ºÎÀÛ¿ëÀÇ °¡´É¼º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå À§³» dz¼± ½ÃÀå : Åõ¿© ¹æ¹ýº°

  • ¼­¹®
  • ³»½Ã°æ
  • Á¤Á¦

Á¦7Àå À§³» dz¼± ½ÃÀå : dz¼± À¯Çüº°

  • ¼­¹®
  • µà¾ó
  • ½Ì±Û
  • Æ®¸®ÇÃ

Á¦8Àå À§³» dz¼± ½ÃÀå : ÃæÀüÀ纰

  • ¼­¹®
  • °¡½º
  • »ý¸® ½Ä¿°¼ö

Á¦9Àå À§³» dz¼± ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¼­¹®
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ À§³» dz¼± ½ÃÀå

  • ¼­¹®
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À§³» dz¼± ½ÃÀå

  • ¼­¹®
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À§³» dz¼± ½ÃÀå

  • ¼­¹®
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Allurion Technologies, Inc.
  • Boston Scientific Corporation
  • Districlass Medical SA
  • Endalis
  • Fengh Medical Co., Ltd.
  • Halexistar Industria Farmaceutica S/A
  • Helioscopie
  • IG Balloon
  • Ilajak Medical
  • KOGLAND Commerce Private Limited
  • Mayo Clinic
  • Medispar NV
  • PlenSat Inc.
  • Ramsay Health Care UK
  • ReShape Lifesciences Inc.
AJY 24.12.20

The Intragastric Balloon Market was valued at USD 20.16 million in 2023, expected to reach USD 21.95 million in 2024, and is projected to grow at a CAGR of 8.25%, to USD 35.12 million by 2030.

The scope of the intragastric balloon market involves its use as a minimally invasive, temporary weight-loss device deployed inside the stomach to aid in weight reduction for individuals struggling with obesity and related comorbidities. The necessity for intragastric balloons arises from the growing prevalence of obesity, increasing awareness of weight management solutions, alongside a preference for non-surgical interventions. These devices are applied predominantly within clinical settings or weight loss facilities, serving as an adjunct to lifestyle modifications, nutritional guidance, and in some cases, pharmacotherapy. Their end-use scope encompasses not only individual patients but also healthcare providers and wellness centers offering comprehensive weight management programs.

KEY MARKET STATISTICS
Base Year [2023] USD 20.16 million
Estimated Year [2024] USD 21.95 million
Forecast Year [2030] USD 35.12 million
CAGR (%) 8.25%

Market growth is principally fueled by rising obesity rates, increasing health consciousness, and advancements in medical technology enhancing the efficacy and safety of intragastric balloons. Moreover, recent regulatory approvals and the incorporation of digital monitoring tools offer potential growth opportunities, allowing businesses to innovate in patient adherence and outcome tracking. Companies can capitalize on these opportunities by exploring integrated mobile applications for patient engagement and data analytics to track progress, providing valuable insights for both patients and healthcare providers. However, market expansion faces limitations from procedural costs, potential side effects, and the need for regular follow-up, which may deter patient adoption. Additionally, a lack of awareness and limited insurance reimbursements pose significant challenges, potentially inhibiting widespread adoption.

Innovations in this sector may focus on developing biodegradable balloons and enhancing balloon materials to increase comfort and safety, as well as researching combinations with emerging weight loss drugs for synergistic effects. The market's competitive nature necessitates a keen focus on pricing strategies and strategic partnerships with healthcare providers to expand reach and accessibility. Overall, the intragastric balloon market presents promising opportunities for those willing to address its limitations through ongoing research, technological integration, and comprehensive market education strategies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intragastric Balloon Market

The Intragastric Balloon Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing obese population due to unhealthy lifestyle and eating habits
    • Patient inclination towards minimally invasive procedures
    • Rising consumer awareness and expenditure on obesity treatments
  • Market Restraints
    • High cost associated with therapy
  • Market Opportunities
    • Rising health tourism trends across several nations
    • Government and private alliance to increase product penetration
  • Market Challenges
    • Possible side effects such as gastric erosion

Porter's Five Forces: A Strategic Tool for Navigating the Intragastric Balloon Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intragastric Balloon Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intragastric Balloon Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intragastric Balloon Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intragastric Balloon Market

A detailed market share analysis in the Intragastric Balloon Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intragastric Balloon Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intragastric Balloon Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intragastric Balloon Market

A strategic analysis of the Intragastric Balloon Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intragastric Balloon Market, highlighting leading vendors and their innovative profiles. These include Allurion Technologies, Inc., Boston Scientific Corporation, Districlass Medical SA, Endalis, Fengh Medical Co., Ltd., Halexistar Industria Farmaceutica S/A, Helioscopie, IG Balloon, Ilajak Medical, KOGLAND Commerce Private Limited, Mayo Clinic, Medispar NV, PlenSat Inc., Ramsay Health Care UK, and ReShape Lifesciences Inc..

Market Segmentation & Coverage

This research report categorizes the Intragastric Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Administration, market is studied across Endoscopy and Pill Form.
  • Based on Balloon Type, market is studied across Dual, Single, and Triple.
  • Based on Filling Material, market is studied across Gas Filled and Saline Filled.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing obese population due to unhealthy lifestyle and eating habits
      • 5.1.1.2. Patient inclination towards minimally invasive procedures
      • 5.1.1.3. Rising consumer awareness and expenditure on obesity treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising health tourism trends across several nations
      • 5.1.3.2. Government and private alliance to increase product penetration
    • 5.1.4. Challenges
      • 5.1.4.1. Possible side effects such as gastric erosion
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intragastric Balloon Market, by Administration

  • 6.1. Introduction
  • 6.2. Endoscopy
  • 6.3. Pill Form

7. Intragastric Balloon Market, by Balloon Type

  • 7.1. Introduction
  • 7.2. Dual
  • 7.3. Single
  • 7.4. Triple

8. Intragastric Balloon Market, by Filling Material

  • 8.1. Introduction
  • 8.2. Gas Filled
  • 8.3. Saline Filled

9. Intragastric Balloon Market, by End-Use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Intragastric Balloon Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Intragastric Balloon Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Intragastric Balloon Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allurion Technologies, Inc.
  • 2. Boston Scientific Corporation
  • 3. Districlass Medical SA
  • 4. Endalis
  • 5. Fengh Medical Co., Ltd.
  • 6. Halexistar Industria Farmaceutica S/A
  • 7. Helioscopie
  • 8. IG Balloon
  • 9. Ilajak Medical
  • 10. KOGLAND Commerce Private Limited
  • 11. Mayo Clinic
  • 12. Medispar NV
  • 13. PlenSat Inc.
  • 14. Ramsay Health Care UK
  • 15. ReShape Lifesciences Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦